Uniphos Enterprises Ltd
₹ 156
1.69%
05 Dec
4:01 p.m.
- Market Cap ₹ 1,087 Cr.
- Current Price ₹ 156
- High / Low ₹ 184 / 113
- Stock P/E 27.8
- Book Value ₹ 379
- Dividend Yield 4.17 %
- ROCE 1.24 %
- ROE 1.23 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Stock is trading at 0.41 times its book value
- Stock is providing a good dividend yield of 4.17%.
- Market value of investments Rs.2,835 Cr. is more than the Market Cap Rs.1,087 Cr.
- Company has been maintaining a healthy dividend payout of 94.6%
- Company's working capital requirements have reduced from 3,710 days to 17.4 days
Cons
- Tax rate seems low
- Company has a low return on equity of 1.42% over last 3 years.
- Earnings include an other income of Rs.43.4 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9 | 1 | 9 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | |
10 | 3 | 10 | 3 | 1 | 2 | 2 | 3 | 2 | 4 | 4 | 4 | 3 | |
Operating Profit | -0 | -2 | -1 | -1 | -1 | -2 | -2 | -3 | -2 | -3 | -3 | -3 | -3 |
OPM % | -3% | -141% | -6% | -47% | -987% | -370% | -257% | -195% | |||||
10 | 2 | 7 | 11 | 14 | 13 | 20 | 24 | 23 | 26 | 57 | 43 | 43 | |
Interest | 9 | 11 | 8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Profit before tax | 1 | -10 | -2 | 9 | 12 | 11 | 18 | 21 | 20 | 23 | 54 | 40 | 40 |
Tax % | -13% | 0% | 0% | 0% | 0% | 0% | 2% | 2% | 2% | -4% | -1% | 1% | |
1 | -10 | -2 | 9 | 12 | 11 | 18 | 21 | 20 | 24 | 55 | 39 | 39 | |
EPS in Rs | 0.17 | -1.46 | -0.23 | 1.23 | 1.70 | 1.62 | 2.54 | 2.99 | 2.89 | 3.52 | 7.85 | 5.64 | 5.62 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 97% | 72% | 115% |
Compounded Sales Growth | |
---|---|
10 Years: | 3% |
5 Years: | % |
3 Years: | 86% |
TTM: | -100% |
Compounded Profit Growth | |
---|---|
10 Years: | 19% |
5 Years: | 17% |
3 Years: | 22% |
TTM: | 0% |
Stock Price CAGR | |
---|---|
10 Years: | 25% |
5 Years: | 11% |
3 Years: | 36% |
1 Year: | 14% |
Return on Equity | |
---|---|
10 Years: | 1% |
5 Years: | 1% |
3 Years: | 1% |
Last Year: | 1% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5 | 5 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
Reserves | 196 | 186 | 249 | 258 | 270 | 2,053 | 2,076 | 2,684 | 1,504 | 2,701 | 3,167 | 2,984 | 2,624 |
86 | 90 | 10 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
10 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 1 | 57 | 121 | 98 | 52 | |
Total Liabilities | 297 | 282 | 281 | 282 | 284 | 2,067 | 2,090 | 2,698 | 1,519 | 2,772 | 3,302 | 3,095 | 2,690 |
174 | 174 | 174 | 174 | 174 | 175 | 175 | 175 | 175 | 176 | 176 | 184 | 184 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 84 | 84 | 84 | 84 | 84 | 1,856 | 1,871 | 2,483 | 1,261 | 2,550 | 3,080 | 2,856 | 2,451 |
39 | 25 | 23 | 24 | 26 | 36 | 44 | 40 | 83 | 46 | 46 | 55 | 55 | |
Total Assets | 297 | 282 | 281 | 282 | 284 | 2,067 | 2,090 | 2,698 | 1,519 | 2,772 | 3,302 | 3,095 | 2,690 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0 | 4 | 5 | -8 | -2 | -2 | -3 | -3 | -2 | -5 | 1 | -1 | |
-1 | 2 | 7 | 10 | 14 | -0 | 9 | -2 | 44 | -34 | 20 | 41 | |
5 | -7 | -14 | -1 | -11 | 0 | 0 | 0 | 0 | 0 | -24 | -39 | |
Net Cash Flow | 3 | -1 | -2 | 1 | 1 | -2 | 5 | -5 | 42 | -38 | -3 | -0 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 365 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 365 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Working Capital Days | 188 | -309 | -282 | -32 | 24,772 | 6,680 | 4,434 | 17 | ||||
ROCE % | 4% | 0% | 2% | 3% | 4% | 1% | 1% | 1% | 1% | 1% | 2% | 1% |
Documents
Announcements
-
Disclosure Under Regulation 30 Of The SEBI [LODR] Regulations, 2015
21h - BSE Limited and the National Stock Exchange of India Limited have imposed fine under Regulation 17 (1A) for delay in compliance with requirements pertaining to …
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 21 Nov
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
9 Nov - Copy of newspaper publications of an extract of unaudited financial results for the quarter and half year ended 30th September, 2023.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 8 Nov
- UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30TH SEPTEMPER, 2023 8 Nov
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Activities[1]
The Co. is engaged in the business of trading chemicals. At present, the trading activities of the Company are on a very small scale. The Company continues to look at new opportunities for trading in chemicals in India and abroad.